Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Statistics

Total Valuation

TARS has a market cap or net worth of $2.02 billion. The enterprise value is $1.78 billion.

Market Cap	2.02B
Enterprise Value	1.78B

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

TARS has 38.23 million shares outstanding. The number of shares has increased by 30.92% in one year.

Current Share Class	38.23M
Shares Outstanding	38.23M
Shares Change (YoY)	+30.92%
Shares Change (QoQ)	+1.48%
Owned by Insiders (%)	8.61%
Owned by Institutions (%)	100.18%
Float	29.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.82
Forward PS	7.20
PB Ratio	8.51
P/TBV Ratio	8.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.42, with a Debt / Equity ratio of 0.31.

Current Ratio	5.42
Quick Ratio	5.27
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21.54

Financial Efficiency

Return on equity (ROE) is -59.56% and return on invested capital (ROIC) is -31.58%.

Return on Equity (ROE)	-59.56%
Return on Assets (ROA)	-27.26%
Return on Capital (ROIC)	-31.58%
Revenue Per Employee	$531,234
Profits Per Employee	-$550,586
Employee Count	244
Asset Turnover	0.40
Inventory Turnover	41.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +176.29% in the last 52 weeks. The beta is 1.04, so TARS's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+176.29%
50-Day Moving Average	46.21
200-Day Moving Average	34.92
Relative Strength Index (RSI)	61.79
Average Volume (20 Days)	540,597

Short Selling Information

The latest short interest is 7.18 million, so 18.78% of the outstanding shares have been sold short.

Short Interest	7.18M
Short Previous Month	7.14M
Short % of Shares Out	18.78%
Short % of Float	24.75%
Short Ratio (days to cover)	7.76

Income Statement

In the last 12 months, TARS had revenue of $129.62 million and -$134.34 million in losses. Loss per share was -$3.70.

Revenue	129.62M
Gross Profit	70.69M
Operating Income	-140.60M
Pretax Income	-150.07M
Net Income	-134.34M
EBITDA	-139.46M
EBIT	-140.60M
Loss Per Share	-$3.70

Balance Sheet

The company has $316.95 million in cash and $73.58 million in debt, giving a net cash position of $243.37 million or $6.37 per share.

Cash & Cash Equivalents	316.95M
Total Debt	73.58M
Net Cash	243.37M
Net Cash Per Share	$6.37
Equity (Book Value)	237.48M
Book Value Per Share	6.22
Working Capital	291.25M

Cash Flow

In the last 12 months, operating cash flow was -$100.18 million and capital expenditures -$1.50 million, giving a free cash flow of -$101.68 million.

Operating Cash Flow	-100.18M
Capital Expenditures	-1.50M
Free Cash Flow	-101.68M
FCF Per Share	-$2.66

Margins

Gross margin is 54.53%, with operating and profit margins of -108.47% and -103.64%.

Gross Margin	54.53%
Operating Margin	-108.47%
Pretax Margin	-103.64%
Profit Margin	-103.64%
EBITDA Margin	-107.59%
EBIT Margin	-108.47%
FCF Margin	n/a

Dividends & Yields

TARS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.92%
Shareholder Yield	-30.92%
Earnings Yield	-6.64%
FCF Yield	-5.03%

Analyst Forecast

The average price target for TARS is $54.20, which is 2.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$54.20
Price Target Difference	2.44%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	95.85%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TARS has an Altman Z-Score of 3.01 and a Piotroski F-Score of 3.

Altman Z-Score	3.01
Piotroski F-Score	3